Tick troponin I-like molecule is a potent inhibitor for angiogenesis.

Microvasc Res

Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan.

Published: May 2006

This is the first report identifying the anti-angiogenesis saliva molecule of the ixodid tick. In our previous study, we identified a troponin I-like molecule (HLTnI) of the ixodid hard tick Haemaphysalis longicornis, a vector for various pathogens. To investigate its potential inhibitory effects for angiogenesis, we expressed and purified recombinant HLTnI in Escherichia coli. In a vascular endothelial growth factor (VEGF) competitive angiogenesis assay, the recombinant HLTnI significantly inhibited the capillary formation of human vascular endothelial cells (HUVEC) in vitro. The inhibition was dose-dependent with an IC(50) of 18.95 nM. These results indicated that HLTnI is a potent angiogenesis inhibitor.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mvr.2006.02.003DOI Listing

Publication Analysis

Top Keywords

troponin i-like
8
i-like molecule
8
recombinant hltni
8
vascular endothelial
8
tick troponin
4
molecule potent
4
potent inhibitor
4
angiogenesis
4
inhibitor angiogenesis
4
angiogenesis report
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!